Deep Nishar
Managing Director and Partner @ General Catalyst
Mountain View, United States
Deep Nishar is a Series A investor at General Catalyst in Mountain View focused on Artificial Intelligence and Software. Deep Nishar is based out of Mountain View, California and is the Managing Director & Partner of General Catalyst. Deep previously worked at SoftBank as a Senior Vice President. Deep Nishar attended Harvard Business School. Deep Nishar has been received Google Founders Award in their career.
- Total investments:
- 47
- Last investment:
- Lead investor:
- 57%
Last updated:
For AI agents: llms.txt
Industries Deep Nishar invests in
Stages Deep Nishar invests in
Countries Deep Nishar invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $600k–$20M
- Series A
- $5.7M–$100M
- Series B
- $32M–$412M
Investment Focus
Industry
- Artificial Intelligence 19 (40%)
- Software 14 (30%)
- Information Technology 11 (23%)
- Machine Learning 10 (21%)
- Biotechnology 7 (15%)
Stage
- Series A 9 (19%)
- Seed 8 (17%)
- Series B 8 (17%)
- Series C 6 (13%)
- Series D 5 (11%)
Country
- United States 31 (66%)
- India 3 (6%)
- Canada 1 (2%)
- Singapore 1 (2%)
- Switzerland 1 (2%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Modular provides an AI infrastructure platform designed for GPU portability and unparalleled performance in AI workloads. The platform features serverless inference endpoints, fine-tuning services, and training clusters to simplify the journey from AI development to production. Modular offers solutions for high-speed LLM serving and cross-hardwarestack management for NVIDIA and AMD environments. | $250M / Series C / Sep 24, 2025 | ||
| Tahoe Therapeutics develops AI-powered tools to simulate human cell responses and guide drug discovery. It operates a platform called Mosaic that produces large-scale single-cell datasets detailing how drug molecules interact with diverse patient cells, with initial applications in oncology. It open-sources its Tahoe-100M dataset, comprisinghundreds of millions of single-cell profiles, to train AI models that build virtual cell models for therapeutic insights. A recent funding round enabled the creation of an even larger dataset, targeting one billion cell datapoints and one million drug-patient interactions, designed to fuel next-generation precision medicines | $30M / Series A / Aug 11, 2025 | ||
| Verkada builds modern security solutions that help enterprises run safer, smarter buildings. Our mission: Modernize the world of enterprise building security.Verkada’s enterprise security solution combines easy to install security cameras, environmental sensors, alarms and access control with intelligent, cloud-based software—all in a scalable,user-friendly system. More than 7800 organizations, including 40 Fortune 500 companies, use Verkada to protect people and assets, secure facilities, and gain new insights that improve the efficiency of their operations. Verkada’s vision is to be the operating system that runs every building in the world.The company was founded by computer scientists and security experts from Stanford University, and Hans Robertson, the former co-founder and COO of Cisco Meraki. Verkada is headquartered in San Mateo, CA with offices in London and Sydney. | $200M / Series E / Feb 19, 2025 | ||
| Nurix AI promotes data quality and integrity to provide accurate generative AI solutions. | $15M / Series A / Sep 24, 2024 | ||
| Kandji is a next-generation Apple device management platform for macOS, iOS, iPadOS, and tvOS. The company builds a sophisticated zero-touch device management solution to help larger companies manage their fleet of Apple devices, including keeping them in compliance with a particular set of rules. The company was founded in 2018 and isheadquartered in San Diego, California. | $100M / Series D / Jul 17, 2024 | ||
| Modular provides an AI infrastructure platform designed for GPU portability and unparalleled performance in AI workloads. The platform features serverless inference endpoints, fine-tuning services, and training clusters to simplify the journey from AI development to production. Modular offers solutions for high-speed LLM serving and cross-hardwarestack management for NVIDIA and AMD environments. | $100M / Series A / Aug 24, 2023 | ||
| Modular provides an AI infrastructure platform designed for GPU portability and unparalleled performance in AI workloads. The platform features serverless inference endpoints, fine-tuning services, and training clusters to simplify the journey from AI development to production. Modular offers solutions for high-speed LLM serving and cross-hardwarestack management for NVIDIA and AMD environments. | Series A / Aug 24, 2023 | ||
|
Georgiamune
|
Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases. | $75M / Series A / Aug 09, 2023 | |
| Adept AI is a research and product AI lab that automates software processes for developers. It's similar to robotic process automation (RPA), or software robots that use a combination of automation, computer vision, and machine learning to automate repetitive tasks like filing forms and responding to emails. Adept is creating generalintelligence by allowing humans and computers to collaborate creatively. | $350M / Series B / Mar 14, 2023 | ||
| Tahoe Therapeutics develops AI-powered tools to simulate human cell responses and guide drug discovery. It operates a platform called Mosaic that produces large-scale single-cell datasets detailing how drug molecules interact with diverse patient cells, with initial applications in oncology. It open-sources its Tahoe-100M dataset, comprisinghundreds of millions of single-cell profiles, to train AI models that build virtual cell models for therapeutic insights. A recent funding round enabled the creation of an even larger dataset, targeting one billion cell datapoints and one million drug-patient interactions, designed to fuel next-generation precision medicines | $12M / Seed / Dec 08, 2022 | ||
| See all 47 investments → | |||
Co-Investors
About General Catalyst
General Catalyst is an investment firm that supports businesses at every stage, from seed to growth. It focuses on fostering resilience and advancing applied AI through its investments. The firm collaborates with entrepreneurs to provide capital and strategic guidance, enabling innovation across industries such as healthcare, fintech, and consumer technology.
General Catalyst Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Christopher Kauffman
Principal
|
|||
Erin Schaefer
COO
|
|||
Genevieve Kinney
Principal
|
|||
James Baum
General Catalyst
|
|||
Jeremy Goldstein
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Deep Nishar invest in?
Deep Nishar invests primarily in Artificial Intelligence, Software and Information Technology startups, most often at Series A and Seed stage. Most of the 47 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Deep Nishar invest in?
Deep Nishar typically joins rounds of $600k–$20M at Seed, $5.7M–$100M at Series A and $32M–$412M at Series B. These are whole funding-round sizes, not Deep Nishar's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Deep Nishar took part in.
How do I contact Deep Nishar?
Public channels for Deep Nishar include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Deep Nishar last invest?
The most recent investment recorded for Deep Nishar closed in Sep 2025. Shizune tracks 47 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
